# Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease

> **NCT03672279** · — · UNKNOWN · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 100 (estimated)

## Conditions studied

- Dementia Alzheimers
- Mild Cognitive Impairment
- Cognition Disorders
- Neurocognitive Disorders

## Interventions

- **DIAGNOSTIC_TEST:** CogCheck

## Key facts

- **NCT ID:** NCT03672279
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-27
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03672279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03672279, "Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03672279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*